A carregar...
Ocular adverse events with immune checkpoint inhibitors
PURPOSE: To quantify the risk of ocular adverse events with immune checkpoint inhibitors (ICIs) as reported to the Food and Drug Administration (FDA). METHODS: Disproportionality analysis using data from U.S. FDA's Adverse Events Reporting System (FAERS) database 2003 to 2018. Data from pharmac...
Na minha lista:
| Publicado no: | J Curr Ophthalmol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6742617/ https://ncbi.nlm.nih.gov/pubmed/31528768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joco.2019.05.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|